References
- Davis G L. Interferon treatment of viral hepatitis in immunocompromised patients. Semin Liver Dis 1989; 9: 267–72
- Zignego A L, Macchia D, Monti M, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus. J Hepatol 1992; 15: 382–6
- Poynard T, Leroy C, Cohard M, et al. Metanalysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996; 24: 778–9
- Booth J CL, Brown J L, Thomas H C. The management of chronic hepatitis C virus infection. Gut 1995; 37: 449–54
- Hoofnagle J H, Lau D. Chronic viral hepatitis - benefits of current therapies. N Engl J Med 1996; 334: 1470–1
- Hoofnagle J H, Di Bisceglie A M. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347–56
- Malaguarnera M, Restuccia S, Trovato G, Siciliano R, Motta M, Trovato B A. Interferon-α treatment in patients with chronic hepatitis C. A meta-analytic evaluation. Clin Drugs Invest 1995; 9: 141–9
- Knodell R G, Ishak K G, Black W C, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–5
- Lau J Y, Mizokami N, Onho T, Diamond D A, Kniffen J, Davis G L. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. Lancet 1993; 342: 1208–9
- Poynard T, Bedossa P, Chevallier M. et al. A comparison of three interferon a-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995; 332: 1457–62
- Saleh M G, Tibbs C J, Koskinas J, et al. Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy. Hepatology 1994; 20: 1399–404